Conexeu Sciences (CNXU)

Currency in USD
10.24
-0.72(-6.57%)
Closed·
10.240.00(0.00%)
·
CNXU is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.1811.40
52 wk Range
9.6018.79
Key Statistics
Prev. Close
10.96
Open
11.1
Day's Range
10.18-11.4
52 wk Range
9.6-18.79
Volume
43.44K
Average Volume (3m)
82.93K
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNXU Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.00
Upside
+95.31%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Conexeu Sciences News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 20.00
(+95.31% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
15-06-2026
EPS / Forecast
-0.11 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CNXU Income Statement

Compare CNXU to Peers and Sector

Metrics to compare
CNXU
Peers
Sector
Relationship
P/E Ratio
−37.8x−4.0x−0.4x
PEG Ratio
-0.050.00
Price/Book
37.9x1.6x2.6x
Price / LTM Sales
-12.6x3.0x
Upside (Analyst Target)
82.5%301.1%57.0%
Fair Value Upside
Unlock4.1%9.1%Unlock

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company’s solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

FAQ

What Is the Conexeu Sciences (CNXU) Share Price Today?

The Conexeu Sciences share price today is 10.24.

What is the current Conexeu Sciences (CNXU) share price and day range?

As of 29-06-2026, the Conexeu Sciences share price is 10.24, with a previous close of 10.96. The share price has ranged from 10.18 to 11.40 today, while the 52-week range spans from 9.60 to 18.79.

What Is the Conexeu Sciences Market Cap?

As of today, Conexeu Sciences market cap is 293.27M.

What Is the Conexeu Sciences (CNXU) Share Price Target?

The average 12-month share price target for Conexeu Sciences is 20.00, with a high estimate of 20 and a low estimate of 20. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +95.31% Upside potential.

What Is Conexeu Sciences's Earnings Per Share (TTM)?

The Conexeu Sciences EPS (TTM) is -0.39.

From a Technical Analysis Perspective, Is CNXU a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Conexeu Sciences Trade On?

Conexeu Sciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Conexeu Sciences?

The stock symbol for Conexeu Sciences is "CNXU."

How Many Times Has Conexeu Sciences Stock Split?

Conexeu Sciences has split 0 times.

What Is the CNXU Premarket Price?

CNXU's last pre-market stock price is 11.85. The pre-market share volume is 720.00, and the stock has changed by 0.89, or 8.12%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.